Department of Orthopaedics, The First Affiliated Hospital of Soochow University, Soochow University, Suzhou, 215006, China.
Orthopaedic Institute, Medical College, Soochow University, Suzhou, 215007, China.
Adv Sci (Weinh). 2023 Apr;10(10):e2206144. doi: 10.1002/advs.202206144. Epub 2023 Jan 22.
Mitochondrial homeostasis is of great importance for cartilage integrity and associated with the progression of osteoarthritis (OA); however, the underlying mechanisms are unknown. This study aims to investigate the role of mitochondrial deacetylation reaction and investigate the mechanistic relationship OA development. Silent mating type information regulation 2 homolog 3 (SIRT3) expression has a negative correlation with the severity of OA in both human arthritic cartilage and mice inflammatory chondrocytes. Global SIRT3 deletion accelerates pathological phenotype in post-traumatic OA mice, as evidenced by cartilage extracellular matrix collapse, osteophyte formation, and synovial macrophage M1 polarization. Mechanistically, SIRT3 prevents OA progression by targeting and deacetylating cytochrome c oxidase subunit 4 isoform 2 (COX4I2) to maintain mitochondrial homeostasis at the post-translational level. The activation of SIRT3 by honokiol restores cartilage metabolic equilibrium and protects mice from the development of post-traumatic OA. Collectively, the loss of mitochondrial SIRT3 is essential for the development of OA, whereas SIRT3-mediated proteins deacetylation of COX4I2 rescues OA-impaired mitochondrial respiratory chain functions to improve the OA phenotype. Herein, the induction of SIRT3 provides a novel therapeutic candidate for OA treatment.
线粒体动态平衡对于软骨完整性至关重要,与骨关节炎(OA)的进展相关;然而,其潜在机制尚不清楚。本研究旨在探讨线粒体去乙酰化反应的作用,并研究其与 OA 发展的机制关系。沉默交配型信息调节 2 同源物 3(SIRT3)的表达与人关节炎软骨和小鼠炎性软骨细胞中的 OA 严重程度呈负相关。全局 SIRT3 缺失加速了创伤后 OA 小鼠的病理性表型,表现为软骨细胞外基质塌陷、骨赘形成和滑膜巨噬细胞 M1 极化。从机制上讲,SIRT3 通过靶向和去乙酰化细胞色素 c 氧化酶亚基 4 同工型 2(COX4I2)来维持线粒体动态平衡,从而防止 OA 进展。霍尼可林对 SIRT3 的激活恢复了软骨代谢平衡,保护小鼠免受创伤后 OA 的发展。总的来说,线粒体 SIRT3 的缺失对于 OA 的发展是必不可少的,而 SIRT3 介导的 COX4I2 蛋白去乙酰化可挽救 OA 受损的线粒体呼吸链功能,改善 OA 表型。因此,SIRT3 的诱导为 OA 治疗提供了一种新的治疗候选药物。